Invion Limited

ASX (AUD): Invion Limited (IVX)

Last Price

0.003

Today's Change

+0.001 (50.00%)

Day's Change

0.002 - 0.003

Trading Volume

7,117,569

Profile
IVX

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Thian Chew Mr. Thian Chew

Full Time Employees:  8 8

IPO Date:  2010-02-14 2010-02-14

CIK: 

ISIN:  AU000000IVX4 AU000000IVX4

CUSIP:  Q4976G108 Q4976G108

Beta:  1.26 1.26

Last Dividend:  0.00 0.00

Dcf Diff:  0.01 0.01

Dcf:  -0.00 -0.00

Description

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

Address

100 Albert Road,
Melbourne, VIC 3205, AU

61 3 9692 7222

http://www.inviongroup.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment